


Ask a doctor about a prescription for LACTEST 0.45 g ORAL SOLUTION POWDER
Package Leaflet: Information for the Patient
LacTEST 0.45 g Powder for Oral Solution
Gaxilosa
Read this package leaflet carefully before using this medicine, as it contains important information for you.
Contents of the Package Leaflet
This medicinal product is for diagnostic use only.
LacTEST is indicated for the non-invasive diagnosis of intestinal lactase deficiency in children and adolescents from 6 years of age, adults, and elderly patients.
Do not useLacTEST:
Warnings and precautions
Consult your doctor before taking LacTEST:
Children and adolescents
LacTEST can be administered to children and adolescents from 6 years of age with normal kidney function.
The safety and efficacy of LacTEST in children from 0 to 5 years of age have not been established .
Using LacTEST with other medicines
Tell your doctor if you are using, have recently used, or might use any other medicines.
Do not take aspirin or indomethacin from 48 hours before the LacTEST test and until the test is completed, as aspirin and indomethacin have been reported to decrease the excretion of xylose in the urine.
It cannot be completely ruled out that there may be an interaction between LacTEST 0.45 g and arabinose contained in some foods. Therefore, patients should be advised to avoid taking foods containing arabinose at least 10 hours (maximum 24 hours) before ingesting LacTEST 0.45 g and until the test is completed.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.
No effects are expected during pregnancy and breastfeeding.
Driving and using machines
The influence of LacTEST on the ability to drive and use machines is negligible or non-existent.
Follow the instructions for administration of this medicine exactly as described in this package leaflet or as directed by your doctor. If you are unsure, consult your doctor.
The recommended dose in adults and the elderly is 0.45 g dissolved in 100 ml of water.
The test should be performed in the following sequence:
For children from 6 to 11 years of age, the test should be performed in the following sequence:
This medicinal product is not authorized for use in children from 0 to 5 years of age.
Use in children and adolescents
LacTEST can be administered to children and adolescents from 6 years of age with normal kidney function.
No dose adjustment is necessary.
This medicinal product is not authorized for use in children from 0-5 years of age.
If you use moreLacTESTthan you should
As only 0.45 g of gaxilosa is administered, an overdose is not expected.
As with all medicines, LacTEST can cause side effects, although not everybody gets them.
The following side effects have been reported:
Uncommon (affects 1 to 10 users in 1,000)
Headache, abdominal distension, abdominal pain, nausea, diarrhea, vomiting, pruritus, urticaria
Frequency not known (cannot be estimated from the available data)
Dizziness, syncope, flatulence, abdominal discomfort, epigastric pain, gastrointestinal noises, skin rash.
Reporting of side effects
If you experience any side effects, talk to your doctor, even if they are not listed in this package leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton. The expiry date is the last day of the month stated.
Do not use this medicine if you notice visible signs of deterioration.
This medicine is stored in sachets; it does not require special temperature conditions for storage.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition ofLacTEST
Appearance of the product and contents of the pack.
LacTEST is presented as a white or almost white powder for oral solution contained in a sachet.
Marketing authorization holder and manufacturer
Marketing authorization holder
Venter Pharma S.L.
Almagro 1, 1º dcha
28010 Madrid
Spain
Manufacturer of the medicinal product
Infarmade, S.L.
Polígono Industrial La Isla
C/ Torre de los Herberos, 35
41703 Dos Hermanas. Sevilla
Spain
Local representative
Juste Farma, S.L.U.
Avda. De San Pablo, 27.
28823 Coslada (Madrid)
Spain
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Spain LacTEST 0.45 g powder for oral solution
Portugal LacTEST 0.45 g powder for oral solution
Date of the last revision of this package leaflet:February 2025
Other sources of information
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/
The average price of LACTEST 0.45 g ORAL SOLUTION POWDER in November, 2025 is around 70.25 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LACTEST 0.45 g ORAL SOLUTION POWDER – subject to medical assessment and local rules.